Table 2: Post-operative, pathological and mid-long term oncological outcomes.
Variable |
N=85 (%) mean±SD |
Median (range) |
30 day/in hospital
mortality |
2 (2.3%) |
|
90-day/in-hospital
mortality |
3 (3.5%) |
|
Post-operative
complications |
35 (41.2%) |
|
Clavien-Dindo classification 2 3a 3b 4a 5 |
23 (27%) 4 (4.7%) 3 (3.5%) 2 (2.4%) 3 (3.5%) |
|
Hospital stay |
11.28±19.7 |
8 (3-180) |
ICU stay |
3.8±19.7 |
1 (1-160) |
Pathological tumor
diameter (mm) |
34±20.8 |
|
pT 0 1a 1b 1c 2a 2b 3 4 |
11 (12.9%) 7 (8.2%) 11 (12.9%) 9 (10.6%) 17 (20%) 11 (12.9%) 11 (12.9%) 8 (9.4%) |
|
pN 0 1 2 |
44 (51.8%) 14 (16.4%) 27 (31.8%) |
|
pN subclassification N1a N1b N2a1 N2a2 N2b |
11 (12.9%) 3 (3.5%) 16 (18.8%) 3 (3.5%) 8 (9.4%) |
|
Mediastinal involvement Single Two station Multiple station |
13 (48.1%) 9 (33.3%) 5 (18.6%) |
|
pStage 0 IA IB IIA IIB IIIA IIIB |
7 (8.2%) 14 (16.5%) 5 (5.9%) 5 (5.9%) 19 (22.4%) 30 (35.3%) 5 (5.9%) |
|
SD: Standard Deviation; ICU: Intensive Care Unit.